Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q3 2016 · 10-Q
Revenue$403.00K$403.00K+269.7% vs Q3 2015 Net Income$30.00K$30.00KN/M vs Q3 2015 EPS Diluted-$0.02-$0.02N/M vs Q3 2015 Operating Income-$1,489,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,449,000N/M Margins · derivedOperating margin-369.5%+1557.1 pt vs Q3 2015
Net margin7.4%+1925.8 pt vs Q3 2015
ended Apr 30, 2016 · filed Jun 9, 2016 · 40 d after period end